Elevance ‘Surprised and Disappointed’ By CMS Medicare Advantage Sanction Threat: CFO

by Becker's Payer | Mar 11, 2026 | CMS, Industry News, Medicare Advantage

Elevance said it was “surprised and disappointed” by a recent CMS sanction threat, which would suspend enrollment in Medicare Advantage prescription drug plans, CFO Mark Kaye said March 10 at the Barclays 28th Annual Global Healthcare Conference in Miami. The...

Medicare Advantage Enrollment Grew by About 1 Million People, Mainly Due to Special Needs Plans

by KFF | Feb 23, 2026 | Industry News, Medicare, Medicare Advantage

The Centers for Medicare & Medicaid Services (CMS) released the latest Medicare Advantage enrollment data on February 13, 2026. These data provide the first look into Medicare Advantage enrollment for 2026 following a statement published by CMS last fall...

3 Legislative Headwinds in Medicare That Agents Can’t Afford to Ignore

by Agent & Advisor | Feb 18, 2026 | Health, Industry News, Medicare, Medicare Advantage

Legislative change in Medicare may feel slow, but the proposals now on the table could reshape how licensed agents sell and support coverage as early as 2026. Lawmakers, regulators, and advocacy groups are signaling three major priorities: new restrictions on Medicare...

Medicare Advantage Threatened by a False Narrative on Costs

by Stat | Feb 5, 2026 | Industry News, Medicare Advantage

For 2026, 2.6 million seniors saw their MA prescription drug plans discontinued, double last year’s total. This erosion is not an accident of the market — it is the direct, predictable consequence of flawed policy, and it’s putting the stability of a vital program in...

Medicare Advantage shifts focus to quality

by InsuranceNewsNet | Feb 3, 2026 | Industry News, Medicare, Medicare Advantage

Medicare Advantage plans face pressure to be profitable, so carriers are shifting their focus to quality. “The entire MA ecosystem is for the benefit of seniors and we must remember that,” said Steve Kaplan, chief legal, compliance and privacy officer at...

How Agents Can Use 2026 Premium Increases to Build Trust and Retention

by Agent and Advisor | Jan 30, 2026 | A&A, Health, Industry News, Medicare, Medicare Advantage

Medicare cost increases are nothing new, but 2026 is shaping up to be a year that beneficiaries will remember. Part B premiums are projected to climb 11.6% to $206.50 — the sharpest jump in dollar terms since 2022. Meanwhile, Part D base premiums are also expected to...